ストックスクリーナーアプリを入手
75.93
1.06%
0.80
プレマーケット:
75.17
-0.76
-1.00%
前日終値:
$75.13
開ける：
$74.89
24時間の取引高:
10.41M
Relative Volume:
1.02
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.03%
1か月 パフォーマンス:
-14.00%
6か月 パフォーマンス:
-23.53%
1年 パフォーマンス:
-10.30%
1日の値動き範囲:
$74.57
$76.16
1週間の範囲:
$71.07
$77.56
52週間の値動き範囲:
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
XBI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
75.93 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
258.75 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
526.41 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
528.67 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
207.02 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
444.10 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf (XBI) 最新ニュース
Alliancebernstein L.P. Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing | U.S. News - Money/ US News
O Shaughnessy Asset Management LLC Has $65,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech stocks to own amid market volatility – Piper Sandler (XBI:NYSEARCA) - Seeking Alpha
Why Summit Therapeutics Rallied Double Digits Today on Another Down day for the Markets - Yahoo Finance
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
How the (XBI) price action is used to our Advantage - news.stocktradersdaily.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - Nasdaq
11 Stocks to Buy After the Biotech Bloodbath - Barron's
Wednesday's ETF Movers: XBI, PICK - Nasdaq
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies - MSN
XBI Crosses Critical Technical Indicator - Nasdaq
Analysts at Cantor, formerly headed by Lutnick, call for Kennedy's dismissal - Reuters
Biotech stocks plunge as FDA’s Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard - TradingView
Bank of New York Mellon Corp Reduces Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com
Trump administration cancels $12 billion in funding to state health departments (XBI:NYSEARCA) - Seeking Alpha
Proficio Capital Partners LLC Buys 5,225 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
Sequoia Financial Advisors LLC Trims Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
How Is Biogen's Stock Performance Compared to Other Biotech Stocks? - TradingView
(XBI) Investment Report - Stock Traders Daily
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Armenian Reporter
Assetmark Inc. Sells 588,528 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Healthcare Sector Trying To Bounce Back - Seeking Alpha
Atria Investments Inc Buys 1,043 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
2Seventy Bio (TSVT): Surge Following Acquisition Announcement - Value The Markets
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by US Bancorp DE - Defense World
Form 424B2 MORGAN STANLEY - StreetInsider.com
Steward Partners Investment Advisory LLC Sells 814 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - The AM Reporter
(XBI) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Guarantor: JPMorgan Chase & Co. - StreetInsider.com
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value the Markets
Jefferies Predicts Up to ~500% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Top-rated biotechs with negative enterprise values - MSN
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
Van ECK Associates Corp Makes New $1.50 Million Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Vontobel Holding Ltd. Has $621,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Allspring Global Investments Holdings LLC Decreases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Mirae Asset Global Investments Co. Ltd. Has $299,000 Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
How to Take Advantage of moves in (XBI) - Stock Traders Daily
Unlocking the Mystery of Smart Beta: A Deep Dive into the iShares Biotechnology ETF - Clinique Bio
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - TradingView
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Can Health Care ETFs Aid Your Portfolio? - ETF Trends
Spdr Biotech Etf (XBI) 財務データ
Spdr Biotech Etf (XBI) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.24%
0.01%
大文字化:
|
ボリューム (24 時間):